Keynote review: Progress in targeting HIV-1 entry
- 1 August 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (16) , 1085-1094
- https://doi.org/10.1016/s1359-6446(05)03550-6
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entryBlood, 2004
- Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for FusionJournal of Biological Chemistry, 2003
- Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 EntryJournal of Biological Chemistry, 2002
- Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kineticsProceedings of the National Academy of Sciences, 2002
- The Catalytic Activity of Protein Disulfide Isomerase Is Involved in Human Immunodeficiency Virus Envelope–Mediated Membrane Fusion after CD4 Cell BindingThe Journal of Infectious Diseases, 2001
- CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and DiseaseAnnual Review of Immunology, 1999
- Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibodyNature, 1998
- Atomic structure of the ectodomain from HIV-1 gp41Nature, 1997
- Core Structure of gp41 from the HIV Envelope GlycoproteinPublished by Elsevier ,1997
- Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction.Proceedings of the National Academy of Sciences, 1994